Octreotide therapy for tumor-induced osteomalacia.
Seufert
J
J
Division of Endocrinology, Metabolism, and Molecular Medicine, Medizinische Poliklinik, University of Würzburg, Germany.
Ebert
K
K
Müller
J
J
Eulert
J
J
Hendrich
C
C
Werner
E
E
Schuüze
N
N
Schulz
G
G
Kenn
W
W
Richtmann
H
H
Palitzsch
K D
KD
Jakob
F
F
D018211:Chondrosarcoma, Mesenchymal / Q000150:complications* / Q000175:diagnosis / Q000378:metabolism; D003951:Diagnostic Errors; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000378:metabolism; D015870:Gene Expression; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D017674:Hypophosphatemia / Q000209:etiology; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010018:Osteomalacia / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D010257:Paraneoplastic Syndromes / Q000188:drug therapy / Q000209:etiology; D010281:Parathyroid Hormone / Q000097:blood; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism; D010758:Phosphorus / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D011877:Radionuclide Imaging; D017481:Receptors, Somatostatin / Q000235:genetics / Q000378:metabolism; D013848:Thigh / Q000000981:diagnostic imaging / Q000473:pathology
D006728:Hormones; D010281:Parathyroid Hormone; D010750:Phosphoproteins; D012333:RNA, Messenger; D017481:Receptors, Somatostatin; D010758:Phosphorus; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23; C093733:somatostatin receptor 2; D015282:Octreotide